GBV-C: State of the art and future prospects

Current HIV/AIDS Reports

Volumn 9, Issue 1, 2012, Pages 26-33

  Maidana Giret, Maria Teresa ^a   Kallas, Esper Georges ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Activation; Co infection; GB virus C (GBV C); Human immunodeficiency virus (HIV); Inhibition

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CXCR4; INTERLEUKIN 2; VIRUS PROTEIN;

ANTIBODY PRODUCTION; ANTIVIRAL THERAPY; B LYMPHOCYTE; CD4 LYMPHOCYTE COUNT; CD8+ T LYMPHOCYTE; COHORT ANALYSIS; COMPETITIVE INHIBITION; CROSS REACTION; DOWN REGULATION; GENOTYPE; GEOGRAPHIC DISTRIBUTION; HEPATITIS G; HEPATITIS G VIRUS; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; INNATE IMMUNITY; LYMPHOCYTE PROLIFERATION; MIXED INFECTION; NONHUMAN; PATHOGENESIS; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; SERODIAGNOSIS; T LYMPHOCYTE ACTIVATION; TH1 CELL; TREATMENT RESPONSE; VIRAL CLEARANCE; VIRUS LOAD; VIRUS REPLICATION; VIRUS TRANSMISSION; DISEASE TRANSMISSION; FLAVIVIRIDAE INFECTION; PATHOGENICITY; PHYSIOLOGY; VIROLOGY; VIRUS HEPATITIS; VIRUS INTERFERENCE;

COINFECTION; FLAVIVIRIDAE INFECTIONS; GB VIRUS C; HEPATITIS, VIRAL, HUMAN; HIV INFECTIONS; HIV-1; HUMANS; VIRAL INTERFERENCE; VIRUS REPLICATION;

EID: 84858994359     PISSN: 15483568     EISSN: 15483576     Source Type: Journal    
DOI: 10.1007/s11904-011-0109-1     Document Type: Review

References (53)

1. Linnen J, Wages Jr J, Zhang-Keck ZY, et al. Molecular cloning and disease association of hepatitis G virus: a transfusion-transmissible agent. Science. 1996;271:505-8. (Pubitemid 26044469)
2. Simons JN, Leary TP, Dawson GJ, et al. Isolation of novel viruslike sequences associated with human hepatitis. Nat Med. 1995;1:564-9.
3. Stapleton JT, Foung S, Muerhoff AS, et al. The GB viruses: a review and proposed classification of GBV-A, GBV-C (HGV), and GBV-D in genus pegivirus within the family Flaviviridae. J Gen Virol. 2011;92:233-46.
4. Ruiz V, Giordano M, Rivero CW, et al. GB virus C quasispecies detected in plasma and lymphocyte subsets in a natural human infection. J Gen Virol. 2010;91:1687-92.
5. Mohr EL, Murthy KK, McLinden JH, et al. The natural history of non-human GB virus C in captive chimpanzees. J Gen Virol. 2011;92:91-100.
6. Alvarado-Mora MV, Botelho L, Nishiya A, et al. Frequency and genotypic distribution of GB virus C (GBV-C) among Colombian population with hepatitis B (HBV) or hepatitis C (HCV) infection. Virol J. 2011;8:345.
7. Giret MT, Miraglia JL, Sucupira MC, et al. Prevalence, incidence density, and genotype distribution of GB virus C infection in a cohort of recently HIV-1-infected subjects in Sao Paulo, Brazil. PLoS One. 2011;6:e18407.
8. Branco C, Esteves A, Piedade J, et al. A new genotype 2 subcluster identified among GBV-C strains circulating in the Lisbon metropolitan area of Portugal. J Med Virol. 2010;82:452-9.
9. Gomara MJ, Fernandez L, Perez T, et al. Assessment of synthetic chimeric multiple antigenic peptides for diagnosis of GB virus C infection. Anal Biochem. 2010;396:51-8.
10. Gomara MJ, Fernandez L, Perez T, et al. Diagnostic value of anti-GBV-C antibodies in HIV-infected patients. Chem Biol Drug Des. 2011;78:277-82.
11. Lefrere JJ, Roudot-Thoraval F, Morand-Joubert L, et al. Carriage of GB virus C/hepatitis G virus RNA is associated with a slower immunologic, virologic, and clinical progression of human immunodeficiency virus disease in coinfected persons. J Infect Dis. 1999;179:783-9. (Pubitemid 29159322)
12. Tillmann HL, Heiken H, Knapik-Botor A, et al. Infection with GB virus C and reduced mortality among HIV-infected patients. N Engl J Med. 2001;345:715-24.
13. Xiang J, Wunschmann S, Diekema DJ, et al. Effect of coinfection with GB virus C on survival among patients with HIV infection. N Engl J Med. 2001;345:707-14.
14. Yeo AE, Matsumoto A, Hisada M, et al. Effect of hepatitis G virus infection on progression of HIV infection in patients with hemophilia. Multicenter hemophilia cohort study. Ann Intern Med. 2000;132:959-63. (Pubitemid 30397596)
15. Williams CF, Klinzman D, Yamashita TE, et al. Persistent GB virus C infection and survival in HIV-infected men. N Engl J Med. 2004;350:981-90. (Pubitemid 38269275)
16. Nunnari G, Nigro L, Palermo F, et al. Slower progression of HIV-1 infection in persons with GB virus C co-infection correlates with an intact T-helper 1 cytokine profile. Ann Intern Med. 2003;139:26-30.
17. Hekmat S, Mohraz M, Vahabpour R, et al. Frequency and genotype of GB virus C among Iranian patients infected with HIV. J Med Virol. 2008;80:1941-6.
18. Campos AF, Tengan FM, Silva SA, et al. Influence of hepatitis G virus (GB virus C) on the prognosis of HIV-infected women. Int J STD AIDS. 2011;22:209-13.
19. Neibecker M, Schwarze-Zander C, Rockstroh JK, et al. Evidence for extensive genotypic diversity and recombination of GB virus C (GBV-C) in Germany. J Med Virol. 2011;83:685-94.
20. Compston LI, Li C, Sarkodie F, et al. Prevalence of persistent and latent viruses in untreated patients infected with HIV-1 from Ghana, West Africa. J Med Virol. 2009;81:1860-8.
21. Ramezani A, Gachkar L, Eslamifar A, et al. Detection of hepatitis G virus envelope protein E2 antibody in blood donors. Int J Infect Dis: IJID: Off Publ Int Soc Infect Dis. 2008;12:57-61. (Pubitemid 350299226)
22. Ramezani A, Mohraz M, Vahabpour R, et al. Frequency of hepatitis G virus infection among HIV positive subjects with parenteral and sexual exposure. J Gastrointestin Liver Dis. 2008;17:269-72.
23. Hosseini-Moghaddam SM, Keyvani H, Samadi M, et al. GB virus type C infection in hemodialysis patients considering co-infection with hepatitis C virus. J Med Virol. 2008;80:1260-3. (Pubitemid 351706006)
24. Bhanich Supapol W, Remis RS, Raboud J, et al. Prevalence and correlates of GB virus C infection in HIV-infected and HIV-uninfected pregnant women in Bangkok, Thailand. J Med Virol. 2011;83:33-44.
25. Supapol WB, Remis RS, Raboud J, et al. Reduced mother-to-child transmission of HIV associated with infant but not maternal GB virus C infection. J Infect Dis. 2008;197:1369-77. (Pubitemid 351706459)
26. Hammad AM, Zaghloul MH. Hepatitis G virus infection in Egyptian children with chronic renal failure (single centre study). Ann Clin Microbiol Antimicrob. 2009;8:36.
27. Xiang J, McLinden JH, Rydze RA, et al. Viruses within the Flaviviridae decrease CD4 expression and inhibit HIV replication in human CD4+ cells. J Immunol. 2009;183:7860-9.
28. Van der Bij AK, Kloosterboer N, Prins M, et al. GB virus C coinfection and HIV-1 disease progression: the Amsterdam cohort study. J Infect Dis. 2005;191:678-85. (Pubitemid 40271054)
29. Maidana-Giret MT, Silva TM, Sauer MM, et al. GB virus type C infection modulates T-cell activation independently of HIV-1 viral load. AIDS. 2009;23:2277-87.
30. Stapleton JT, Chaloner K, Zhang J, et al. GBV-C viremia is associated with reduced CD4 expansion in HIV-infected people receiving HAART and interleukin-2 therapy. Aids 2009.
31. Blankson JN, Klinzman D, Astemborski J, et al. Low frequency of GB virus C viremia in a cohort of HIV-1-infected elite suppressors. AIDS. 2008;22:2398-400.
32. Schwarze-Zander C, Neibecker M, Othman S, et al. GB virus C coinfection in advanced HIV type-1 disease is associated with low CCR5 and CXCR4 surface expression on CD4(+) T-cells. Antivir Ther. 2010;15:745-52.
33. Barbosa Ade J, Baggio-Zappia GL, Dobo C, et al. Analysis of GB virus C infection among HIV-HCV coinfected patients. Rev Soc Bras Med Trop. 2009;42:591-3.
34. Boodram B, Hershow RC, Klinzman D, et al. GB virus C infection among young, HIV-negative injection drug users with and without hepatitis C virus infection. J Viral Hepat. 2011;18:e153-9.
35. Hofer H, Aydin I, Neumueller-Guber S, et al. Prevalence and clinical significance of GB virus type C/hepatitis G virus coinfection in patients with chronic hepatitis C undergoing antiviral therapy. J Viral Hepat. 2011;18:513-7.
36. Berzsenyi MD, Woollard DJ, McLean CA, et al. Down-regulation of intra-hepatic T-cell signaling associated with GB virus C in a HCV/HIV co-infected group with reduced liver disease. J Hepatol 2011.
37. Lalle E, Sacchi A, Abbate I, et al. Activation of interferon response genes and of plasmacytoid dendritic cells in HIV-1 positive subjects with GB virus C co-infection. Int J Immunopathol Pharmacol. 2008;21:161-71. (Pubitemid 351501012)
38. Moenkemeyer M, Schmidt RE, Wedemeyer H, et al. GBV-C coinfection is negatively correlated to Fas expression and Fas-mediated apoptosis in HIV-1 infected patients. J Med Virol. 2008;80:1933-40.
39. Xiang J, McLinden JH, Chang Q, et al. Characterization of a peptide domain within the GB virus C NS5A phosphoprotein that inhibits HIV replication. PLoS One. 2008;3:e2580.
40. McLinden JH, Stapleton JT, Chang Q, et al. Expression of the dengue virus type 2 NS5 protein in a CD4(+) T cell line inhibits HIV replication. J Infect Dis. 2008;198:860-3.
41. Mohr EL, Xiang J, McLinden JH, et al. GB virus type C envelope protein E2 elicits antibodies that react with a cellular antigen on HIV-1 particles and neutralize diverse HIV-1 isolates. Journal of immunology 2010, 185: 4496-4505.
42. Perez-Lopez S, Vila-Romeu N, Alsina Esteller MA, et al. Interaction of GB Virus C/Hepatitis G Virus Synthetic Peptides with Lipid Langmuir Monolayers and Large Unilamellar Vesicles. J Phys Chem B 2008.
43. Sanchez-Martin MJ, Amigo JM, Pujol M, et al. Fluorescence study of the dynamic interaction between E1(145-162) sequence of hepatitis GB virus C and liposomes. Anal Bioanal Chem. 2009;394:1003-10.
44. Perez-Lopez S, Nieto-Suarez M, Mestres C, et al. Behaviour of a peptide sequence from the GB virus C/hepatitis G virus E2 protein in Langmuir monolayers: its interaction with phospholipid membrane models. Biophys Chem. 2009;141:153-61.
45. Herrera E, Gomara MJ, Mazzini S, et al. Synthetic peptides of hepatitis G virus (GBV-C/HGV) in the selection of putative peptide inhibitors of the HIV-1 fusion peptide. J Phys Chem B. 2009;113:7383-91.
46. Haro I, Gomara MJ, Galatola R, et al. Study of the inhibition capacity of an 18-mer peptide domain of GBV-C virus on gp41-FP HIV-1 activity. Biochim Biophys Acta. 2011;1808:1567-73.
47. Koedel Y, Eissmann K, Wend H, et al. Peptides derived from a distinct region of GB virus C glycoprotein E2 mediate strain-specific HIV-1 entry inhibition. J Virol. 2011;85:7037-47.
48. Sanchez-Martin MJ, Hristova K, Pujol M, et al. Analysis of HIV-1 fusion peptide inhibition by synthetic peptides from E1 protein of GB virus C. J Colloid Interface Sci. 2011;360:124-31.
49. Sanchez-Martin MJ, Busquets MA, Girona V, et al. Effect of E1 (64-81) hepatitis G peptide on the in vitro interaction of HIV-1 fusion peptide with membrane models. Biochim Biophys Acta. 2011;1808:2178-88.
50. Sanchez-Martin MJ, Urban P, Pujol M, et al. Biophysical Investigations of GBV-C E1 Peptides as Potential Inhibitors of HIV-1 Fusion Peptide. Chemphyschem : a European journal of chemical physics and physical chemistry 2011.
51. Herrera E, Tenckhoff S, Gomara MJ, et al. Effect of synthetic peptides belonging to E2 envelope protein of GB virus C on human immunodeficiency virus type 1 infection. J Med Chem. 2010;53:6054-63.
52. Stapleton JT, Chaloner K, Zhang J, et al. GBV-C viremia is associated with reduced CD4 expansion in HIV-infected people receiving HAART and interleukin-2 therapy. AIDS. 2009;23:605-10.
53. Mohr EL, Stapleton JT. GB virus type C interactions with HIV: the role of envelope glycoproteins. J Viral Hepat. 2009;16:757-68.